Telmisartan Tablet
Product Images NDC 71209-051

12 FDA label images from Cadila Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Telmisartan (NDC 71209-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Telmisartan-20mg-blister-carton (Telmisartan 20mg Blister Carton)

Telmisartan-20mg-blister-carton (Telmisartan 20mg Blister Carton)
Packaging label for Telmisartan Tablets USP 20 mg by Cadila Pharmaceuticals Limited. The label indicates a package of 30 tablets in a 3x10 unit dose format. It includes dosage instructions to read accompanying prescribing information and a note on moisture sensitivity advising not to remove tablets from the blister until immediately before administration. The label includes multiple barcodes and specifies storage at controlled room temperature.*
FDA Label Image

Telmisartan-20mg-blister-cr-carton (Telmisartan 20mg Blister Cr Carton)

Telmisartan-20mg-blister-cr-carton (Telmisartan 20mg Blister Cr Carton)
Packaging label for Telmisartan Tablets USP 20 mg oral tablets by Cadila Pharmaceuticals Limited. The label indicates 30 tablets in a child-resistant unit dose pack. It states that each tablet contains 20 mg of telmisartan, with instructions to read accompanying prescribing information. The pack features a purple and white design with the company logo and barcode.*
FDA Label Image

Telmisartan-40mg-blister-carton (Telmisartan 40mg Blister Carton)

Telmisartan-40mg-blister-carton (Telmisartan 40mg Blister Carton)
Packaging label for Telmisartan Tablets USP 40 mg oral tablets by Cadila Pharmaceuticals Limited. The label indicates 30 tablets per pack (3 x 10 unit dose), with instructions to read accompanying prescribing information. It highlights the tablets are moisture sensitive and should not be removed from the blister until just before administration. The label includes barcode and branding with blue and white design elements.*
FDA Label Image

Telmisartan-40mg-blister-cr-carton (Telmisartan 40mg Blister Cr Carton)

Telmisartan-40mg-blister-cr-carton (Telmisartan 40mg Blister Cr Carton)
Packaging label for Telmisartan Tablets USP 40 mg by Cadila Pharmaceuticals Limited. The label is for a child-resistant pack containing 30 tablets (3x10 unit dose). Text highlights the active ingredient strength and includes a caution about moisture sensitivity and prescribing information. The label features the Cadila Pharmaceuticals logo and includes a placeholder for a 2D barcode.*
FDA Label Image

Telmisartan-80mg-blister-carton (Telmisartan 80mg Blister Carton)

Telmisartan-80mg-blister-carton (Telmisartan 80mg Blister Carton)
Packaging label for Telmisartan Tablets USP 80 mg by Cadila Pharmaceuticals Limited. The label indicates a package containing 30 tablets (3x10 unit dose). It includes directions to read accompanying prescribing information and a warning that tablets are moisture sensitive and should not be removed from the blister until immediately before administration.*
FDA Label Image

Telmisartan-80mg-blister-cr-carton (Telmisartan 80mg Blister Cr Carton)

Telmisartan-80mg-blister-cr-carton (Telmisartan 80mg Blister Cr Carton)
Packaging label for Telmisartan Tablets USP 80 mg, oral tablet form, manufactured by Cadila Pharmaceuticals Limited, India. The label indicates a 30 tablet count (3x10 unit dose) in a child-resistant container. Key text includes dosage strength 80 mg and a note about moisture sensitive tablets advising not to remove from blister until immediately before administration. The label displays NDC 71209-051-18.*
FDA Label Image

Telmisartan-fig2 (Telmisartan Fig2 Crblister)

Telmisartan-fig2 (Telmisartan Fig2 Crblister)
An instructional illustration showing a hand pushing a tablet through a blister pack, demonstrating the method to remove the tablet from the packaging.*
FDA Label Image

Telmisartan-fig3 (Telmisartan Fig3 Crblister)

Telmisartan-fig3 (Telmisartan Fig3 Crblister)
Illustration showing hands opening a small packet by tearing along a notch, likely demonstrating how to open a foil pouch or sachet commonly used for packaging tablets or other oral dosage forms.*
FDA Label Image

Telmisartan-fig4 (Telmisartan Fig4 Crblister)

Telmisartan-fig4 (Telmisartan Fig4 Crblister)
An instructional diagram depicting a person opening a tablet blister pack by pressing a tablet through the foil backing with their thumb, illustrating the correct method to remove a tablet.*
FDA Label Image

Telmisartan-fig5 (Telmisartan Fig5 Blister)

Telmisartan-fig5 (Telmisartan Fig5 Blister)
An instructional diagram showing a hand pressing a tablet through the foil of a blister pack, illustrating how to remove a tablet from the packaging.*
FDA Label Image

Telmisartan-fig6 (Telmisartan Fig6 Blister)

Telmisartan-fig6 (Telmisartan Fig6 Blister)
An instructional illustration showing a hand preparing to peel or open a package, likely demonstrating how to access a tablet or blister pack. The image depicts fingers lifting or pressing a tab with an arrow indicating the direction of motion.*
FDA Label Image

Telmisartan-fig1 (Telmisartan Stru)

Telmisartan-fig1 (Telmisartan Stru)
Chemical structure of the active ingredient Telmisartan, showing its molecular framework including multiple aromatic rings and functional groups characteristic of this antihypertensive agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.